- authorisedTherapeutic exploratory (Phase II)
A Phase 2, Open-label, Multicenter Study to Determine the Safety, Tolerability, and Efficacy of MK- 1045 in Participants with Hematologic Malignancies
This phase 2 clinical trial is looking at an experimental drug called MK-1045 for adults with certain types of blood cancer, known as CLL and SLL. Doctors want to see how safe the drug is, what side effects it might cause, and how well it helps treat the cancer.
Spain · Italy - recruitingPHASE3
Global Trial in APG2575 for Patients With CLL/SLL
This study is looking into a new treatment called lisaftoclax for people with a type of blood cancer called CLL/SLL. It compares adding lisaftoclax to an existing BTK inhibitor treatment versus just using the BTK inhibitor alone, for patients who have already been on BTK inhibitors.
United States · Australia · Belgium - active not recruiting
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
This study looks at how chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL) are treated in real life across France. Researchers want to see how different treatments affect patients over time and gather information to improve care for people with these conditions.
France